NBC-ReGen4 · Nanostructured & Biomimetic Ceramic-Polymer Composites for Bone Tissue Regeneration
FP7 — People (Marie Curie Actions)
- Duration
- 2012-09-01 → 2014-08-31
- EU contribution
- €200,372
- Participants
- 1
- Scheme
- MC-IEF
Lines connect the coordinator with its partners.
Results in brief
Nanostructured & Biomimetic Ceramic-Polymer Composites for Bone Tissue Regeneration
Today, there is no doubt that small-scale (nano-) complex materials made up of distinct components (composites) may, if prepared correctly, show substantially improved properties that offer several potential advantages related to their clinical application in medicine and dental surgery. Published data reports the superior properties of nano-composites and explain why interactions at the nano-scale are responsible for observed differences when compared to large-scale (macro- and micro-) composites. Despite this growing evidence base, very few nano-materials have been placed on the market as medical devices for the repair of human tissues, such as restorative dental fillings where it was reported they provide superior properties and good wear characteristics. In NBC-ReGen4 project, we proposed the development of an innovative not-biological and biodegradable nano-composite as a valuable new technological approach that offers great potential as a platform for new commercial product development. These innovative composites, based on combinations of nanoscale bioceramic particles with synthetic polymers will: (1) eliminate the risk of disease transmission associated with existing collagen-based devices and scaffolds, (2) offer opportunities to tailor the material properties - including its biodegradation characteristics - to a given clinical situation, (3) enable fabrication of complex layered structures with an optimized bone-facing surface, and finally (4) be more appropriate for use in countries and cultures where implantation of animal-derived products is undesirable. In addition to developing new materials technologies for medical devices, the scientific and technological elements of this programme have wider medical applications, for example in the fabrication of scaffolds for skeletal tissue engineering and in particular in guided bone regeneration. Different bioresorbable membrane products are available on the market such as Guidor® Matrix Barrier, Resolut® and Epi-Guide ® Bioresorbable Barrier Matrix which are layered membranes based on synthetic polymers. Their main drawbacks of these products are related to the lack of functionalities stimulating bone regeneration and wound healing, and exerting antimicrobial activity. Therefore the absorbable functionalised multilayered membranes developed in NBC-ReGen4 (1) represent highly innovative products with a minimal rise in the product costs to allow their rapid spread on the market, and (2) are of tremendous potential benefit to the European medical device and health technology business sector. In the details, crucial activity of the project was the membrane surface modification in order to enhance the biomimetic and anti-inflammatory properties by low-risk and environmentally friendly techniques (characterised by room temperature processing and low-cost manufacturing). The compact layer, in contact to soft tissue, was modified by layer-by-layer technique to obtain nano-scale layers, in which incorporate the metronidazole, a common antibiotic used in the periodontitis treatment preventing bacterial colonization. The biocompatibility was successfully evaluated in vitro with soft tissue cells and the antibacterial properties were demonstrated successfully against the keystone periodontal bacteria. On the other hand, the porous membrane in contact to bone were modified successfully by specific chemical reaction to incorporate specific bone peptide sequences able to enhance successfully the formation of new bone.
Data: CORDIS, © European Union
Project objective
The interdisciplinary proposal NBC-ReGen4 is based on the existing expertise in materials science of the incoming European Fellow (Dr. Piergiorgio Gentile) in combination with the host laboratories knowledge of biocompatibility assessment and medical device development (University of Sheffield-Scientist in charge: Prof. P.V. Hatton). NBC-ReGen4 is a timely project with respect to the scientific and technological advance on the state-of-the-art and with clear translational relevance to industry and ultimately patients. It aims to produce, characterise and evaluate a series of nanostructured composites with significantly improved properties compared to the existing state-of-the-art, specifically including suitable membranes for guided bone regeneration. Conceptually, the adaptation of nanostructured composite membranes for the development of functional devices in different applications represents a major step forward in the increasingly competitive field of tissue engineering and regenerative medicine. It is also an ideal time to train a talented materials scientist in new methods related to biological evaluation of a biomaterial, as well as transferable skills that will significantly boost his career prospects and opportunities to contribute to society. In detail, in NBC-ReGen4 the innovative composite membranes will be based on commercially available or in-house fabricated calcium phosphate particles incorporated into a resorbable medical polymer matrix (polyglycolic acid or poly(lactide co-glycolide)) further processed by electrospinning. The obtained composite membrane will consist in bilayered structures that can be modified and characterised for specific applications where bone tissue regeneration is required on only one side. Surface functionalization of the different layers to enhance specific properties (such as biomimetic and anti-inflammatory properties) by low-risk and environmentally-friendly techniques, will be also implemented.
Original text from CORDIS.
Participants
- THE UNIVERSITY OF SHEFFIELD · SHEFFIELDCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union
